EUVIMEDEUVIMED entdecken
Crossref

A liquid chromatography–tandem mass spectrometry method for therapeutic drug monitoring of treosulfan

Jeayeon Ryu iD, Sollip Kim iD, Sang-Hee Lee iD, Sung Han Kang iD, Woochang Lee iD, Sail Chun iD, Ho Joon Im iD

Laboratory Medicine · 03.04.2026 · 57 (3)

DOI: 10.1093/labmed/lmag017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, online erschienen am 28.04.2026. Verfasst von Jeayeon Ryu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Busulfan, Tandem Mass Spectrometry, Drug Monitoring, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Treosulfan is an alkylating agent administered before hematopoietic stem cell transplantation. Because pharmacokinetic parameters exhibit interindividual variability, therapeutic drug monitoring may be necessary. In this study, a liquid chromatography–tandem mass spectrometry method for monitoring treosulfan was developed and validated.

Methods

Treosulfan was separated from 25 µL plasma after protein precipitation with acetonitrile. Treosulfan-D4 was used as the internal standard. Separation was performed using an ACQUITY UPLC Ι-Class PLUS System (Waters Corporation) coupled with a Xevo TQ-XS Mass Spectrometer (Waters Corporation). Limit of quantification, selectivity, linearity, imprecision, carryover, matrix effect, and stability were validated according to Clinical and Laboratory Standards Institute guidelines.

Results

The mass-to-charge transitions were treosulfan 296.2 > 87.1 and treosulfan-D4 300.2 > 91.1. The total run time was 4 minutes. The limit of quantification of treosulfan was 3.13 µg/mL. The calibration curve was linear in the 3.13 to 100-µg/mL range. The method was adequately selective and without carryover or matrix effect. Treosulfan was stable in plasma for 2 hours at room temperature and for up to 3 days and 1 week when stored at 10 °C and ‒20 °C, respectively.

Discussion

Our liquid chromatography–tandem mass spectrometry method for measuring treosulfan met Clinical and Laboratory Standards Institute validation requirements and exhibited robust performance, suggesting its utility for therapeutic drug monitoring in clinics treating patients with treosulfan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BusulfanTandem Mass SpectrometryDrug MonitoringLiquid Chromatography-Mass SpectrometryAntineoplastic Agents, AlkylatingHumansReproducibility of ResultsChromatography, Liquid

Stichwörter der Autor:innen

CLSILC-MS/MSalkylating agenthematopoietic stem cell transplanttherapeutic drug monitoringtreosulfan

Substanzen

treosulfanBusulfanAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.
  • Institute of Digital Healthcare, University of Ulsan College of Medicine, Seoul, Korea.
  • Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan, College of Medicine, Seoul, Korea.

ORCID-Profile: Jeayeon Ryu, Sollip Kim, Sang-Hee Lee, Sung Han Kang, Woochang Lee, Sail Chun, Ho Joon Im

Zitieren

APA

Ryu, J., Kim, S., Lee, S. H., Kang, S. H., Lee, W., Chun, S., & Im, H. J. (2026). A liquid chromatography–tandem mass spectrometry method for therapeutic drug monitoring of treosulfan. Laboratory Medicine, 57(3). https://doi.org/10.1093/labmed/lmag017

Vancouver

Ryu J, Kim S, Lee SH, Kang SH, Lee W, Chun S, et al. A liquid chromatography–tandem mass spectrometry method for therapeutic drug monitoring of treosulfan. Laboratory Medicine. 2026;57(3). doi:10.1093/labmed/lmag017

BibTeX
@article{Ryu2026,
  author = {Ryu, Jeayeon and Kim, Sollip and Lee, Sang-Hee and Kang, Sung Han and Lee, Woochang and Chun, Sail and Im, Ho Joon},
  title = {A liquid chromatography–tandem mass spectrometry method for therapeutic drug monitoring of treosulfan},
  journal = {Laboratory Medicine},
  year = {2026},
  volume = {57},
  number = {3},
  doi = {10.1093/labmed/lmag017}
}
Kostenlos starten →